Financial Toxicity in a Phase I/II Trial of LV20.19 CAR-T Cell for B-cell Malignancies: A Longitudinal, Qualitative Study

Transplantation and Cellular Therapy 2026 Open access

Read full text
Authors: Elizabeth Aughey, Nirav Niranjan Shah, Cecilia J. Hillard, Kelly E. Rentscher, Mehdi Hamadani, Walter Longo, Suma Devata, Jennifer M. Knight, Rachel N. Cusatis
DOI: 10.1016/j.jtct.2025.12.1000
Cited by: 0
References: 36

Fields of Study & Subjects

Economic and Financial Impacts of Cancer CAR-T cell therapy research Health Systems Economic Evaluations Quality of Life

Publication details

Journal / source
Transplantation and Cellular Therapy
Volume
32
Issue
5
Pages
621.e1–621.e11
Publication date
2 January 2026
Language
EN